Decibel Therapeutics, Inc.
DBTXDelisted Sep 25, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001656536
Decibel Therapeutics, Inc. was delisted on Sep 25, 2023; its insiders filed their last Form 4 on Sep 25, 2023; 37 institutions reported holding it in 13F filings for Q2 2023, worth $59.2M in total; no superinvestor held it.
Q1 2022 vs. Q4 2021
How the institutions holding Decibel Therapeutics, Inc. changed between Q4 2021 and Q1 2022.
All holders in Q1 2022All holders in Q4 2021
| Measure | Q4 2021 | Q1 2022 | Change |
|---|---|---|---|
| Holders | 40 | 39 | −1 |
| Shares | 17.6M | 17.7M | +131.9K (+0.8%) |
| Value | $81.7M | $53.8M | −$27.9M (−34.1%) |
New holders (4)
Institutions that held Decibel Therapeutics, Inc. at the end of Q1 2022 but not at the end of Q4 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Barclays PLC | 240,337 | $731.0K | 0.00% |
| MYDA Advisors LLC | 20,000 | $61.0K | 0.03% |
| Bailard, Inc. | 19,700 | $60.0K | 0.00% |
| FNY Investment Advisers, LLC | 3,200 | $9.00K | 0.01% |
Sold out (5)
Institutions that held Decibel Therapeutics, Inc. at the end of Q4 2021 and filed for Q1 2022 without it.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| FMR LLC | 43,500 | $202.0K |
| Two Sigma Advisers, LP | 11,300 | $53.0K |
| Optiver Holding B.V. | 867 | $7.00K |
| Royal Bank of Canada | 1,075 | $5.00K |
| UBS Group AG | 95 | $0 |